Support systems that provide clinicians with individualized health information will see strong growth as healthcare organizations become more focused on meeting quality performance measures and transitioning away from volume-based care.
“The introduction of value-based reimbursements and quality performance measures will increase the value of evidence-based data to document a clinical rationale and support medical decision making,” said Victor Camlek, digital health principal analyst at Frost & Sullivan.
In total, Frost & Sullivan estimated the U.S. clinical decision support system market will be valued at $4.97 billion by 2021.
However, these systems will hinge on information available in EHRs, as clinical decision support relies on large volumes of data to inform point-of-care feedback. Healthcare organizations should be able leverage growing amounts of patient data, but lack of EHR interoperability may hinder this exchange.
More articles on health IT:
UChicago Medicine and Google — a data-driven duo to watch
KLAS: Optimum Healthcare IT ranks No. 1 consulting firm for IT implementation, go-live support
Family physicians to FCC: Net neutrality is ‘paramount’ for US healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.